The Latin America, Middle East and Africa AI In Drug Repurposing Market would witness market growth of 21.8% CAGR during the forecast period (2025-2032).
The Brazil market dominated the LAMEA AI In Drug Repurposing Market by Country in 2024, and would continue to be a dominant market till 2032; thereby, achieving a market value of $128.9 million by 2032. The Argentina market is showcasing a CAGR of 22.8% during (2025 - 2032). Additionally, The UAE market would register a CAGR of 20.6% during (2025 - 2032). The Brazil and UAE led the LAMEA AI In Drug Repurposing Market by Country with a market share of 39.4% and 13.8% in 2024. The Nigeria market is expected to witness a CAGR of 24.7% during throughout the forecast period.
AI-driven drug repurposing is growing in the LAMEA region. It started in schools and with opportunistic projects, but now it's moving toward a structured innovation ecosystem supported by the growth of digital health, the maturation of biobanks, and government-backed biotech modernization. Latin America is seeing health AI projects as part of national AI programs. Africa and the Middle East, on the other hand, are using partnerships and collaborations with global biotech companies that are funded by donors. These changes show a shift from small, separate pilot studies to focused AI applications that deal with regional disease burdens and problems with data sovereignty.
Three important trends are shaping this evolution: putting more emphasis on diseases that are common in certain areas but often ignored, using federated and privacy-preserving AI models to get around data-sharing problems, and forming strategic international partnerships to share knowledge and technology. Competition is still new and not very strong. Local startups and research institutions are focusing on niche diseases, cost-effectiveness, ease of understanding, and following local rules. Companies are increasingly looking for hybrid service-licensing models and partnerships with global players to get ready for future consolidation and to become leaders in AI-enabled drug repurposing in their regions.
Based on Component, the market is segmented into Software & Platform, and Services. The Software & Platform market segment dominated the South Africa AI In Drug Repurposing Market by Component is expected to grow at a CAGR of 22.5 % during the forecast period thereby continuing its dominance until 2032. Also, The Services market is anticipated to grow as a CAGR of 23.6 % during the forecast period during (2025 - 2032).
Based on Application, the market is segmented into Oncology, Neurology, Infectious Diseases, Rare & Orphan Diseases, Cardiology, and Other Application. Among various Brazil AI In Drug Repurposing Market by Application; The Oncology market achieved a market size of USD $10.1 Million in 2024 and is expected to grow at a CAGR of 19.2 % during the forecast period. The Cardiology market is predicted to experience a CAGR of 21.8% throughout the forecast period from (2025 - 2032).
Free Valuable Insights: The Worldwide AI In Drug Repurposing Market is Projected to reach USD 4.11 Billion by 2032, at a CAGR of 19.7%
Brazil is the leader for AI-driven drug repurposing in Latin America. This is because it has a strong life sciences ecosystem, good academic and research institutions, and a large and diverse patient population. The country's growing digital health infrastructure, government interest in biotechnology, and large amounts of clinical data from the public health system (SUS) make it easy for AI to be used. Key opportunities exist in tackling high-burden tropical and chronic diseases via cost-effective repurposing strategies, the utilization of generative AI, and localized validation. Brazil has the potential to be a regional leader in AI-enabled drug repurposing because it has a mature scientific community, strong industrial capabilities, and new partnerships. However, there are still challenges like data fragmentation, changing regulations, and uneven infrastructure.
By Component
By Technology
By End Use
By Application
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 